Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Bruker and ImaBiotech Announces Collaboration

Published: Friday, June 21, 2013
Last Updated: Friday, June 21, 2013
Bookmark and Share
Bruker to distribute ImaBiotech's Quantinetix software for quantitative MALDI imaging.

Bruker and ImaBiotech have announced a collaboration for the distribution of ImaBiotech’s Quantinetix™ software. The Quantinetix software is the first independent multi-format software for MALDI instruments that quantifies and normalizes molecules.

Mass spectrometry MALDI imaging is a technique that allows for the direct detection of drugs and metabolites in tissue, and it is increasingly being adopted as a tool for pharmaceutical drug discovery and development.

But the absolute quantification of MALDI imaging data is challenging due to the complex matrix used (intact tissue) and the associated suppression of the ions that are essential to the measurement process.

ImaBiotech, a leading service provider for MALDI imaging, has incorporated its special quantification methods into the Quantinetix™ dedicated software package to address these challenges.

Quantinetix™ is user-friendly software that provides quantitation of target compounds following mass spectrometry imaging experiments.

It normalizes and quantifies molecules in several ways, providing images and quantitation of target compounds in over 25 organs when used for whole body distribution imaging, as well as for individual organs in targeted applications.

Dr. Sören-Oliver Deininger, Market Area Manager for MALDI Imaging at Bruker, noted, “ImaBiotech‘s Quantinetix™ software has helped transform MALDI imaging into a quantitative technique. With this collaboration, we are now able to directly provide our customers with the benefits of Quantinetix™, enabling them to achieve true quantitative results with their Bruker MALDI molecular imaging solution.”

Dr. Jonathan Stauber, CEO of ImaBiotech, added, “We are pleased to partner with Bruker. ImaBiotech’s know-how and efficiency in imaging complement Bruker’s renowned expertise in mass spectrometry. With this agreement, we are now able to offer this unparalleled technology to molecular researchers in the worldwide pharmaceutical and biomedical research industries.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Bruker Opens New Preclinical Imaging Center of Excellence for the Americas
Massachusetts Center will provide advanced development, demonstration and customer support capabilities for Bracer’s unique multimodal preclinical imaging systems portfolio.
Thursday, January 30, 2014
Bruker Announces Acquisition of Prairie Technologies
Acquisition strengthens Bruker Nano Surfaces Division's position in life science markets.
Friday, September 13, 2013
Bruker to Acquire Carestream’s Preclinical In-vivo Imaging Business
Transaction positions in-vivo products for long-term growth.
Monday, September 24, 2012
Scientific News
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Self-Propelled Powder to Stop Bleeding
UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.
Tension Helps Heart Cells Develop Normally in the Lab
Stanford engineers have uncovered the important role tension plays in growing heart cells out of the body.
Controlling Body Temperature in Response to 'Fight or Flight'
New research in The FASEB Journal suggests that blocking TRPV1 protein causes an increased release of noradrenaline, leading to an increase in core body temperatures.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
A Fundamental Protection Mechanism Against Formalin In Mammals is Revealed
Formaldehyde, or formalin, is well known to all of us as a common chemical used in many industrial processes and also as a preservative, remarkably we also produce formaldehyde in our bodies.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos